Sarepta Therapeutics (United States) (Q333576): Difference between revisions

From geokb

Latest revision as of 15:12, 10 September 2024

company organization in Cambridge, United States

AVI BioPharma
Sarepta Therapeutics and SRPT
AntiVirals

Language	Label	Description	Also known as
English	Sarepta Therapeutics (United States)	company organization in Cambridge, United States	AVI BioPharma Sarepta Therapeutics and SRPT AntiVirals

Statements

0 references

addresses subject

Molecular Mechanisms of Muscle Regeneration and Atrophy

203

1 reference

https://openalex.org/I4210148120

Gene Therapy Techniques and Applications

85

1 reference

https://openalex.org/I4210148120

Mechanisms and Applications of RNA Interference

73

1 reference

https://openalex.org/I4210148120

DNA Nanotechnology and Bioanalytical Applications

44

1 reference

https://openalex.org/I4210148120

Gene Therapy for Spinal Muscular Atrophy

40

1 reference

https://openalex.org/I4210148120

Diagnosis and Management of Hypertrophic Cardiomyopathy

35

1 reference

https://openalex.org/I4210148120

Regulation of RNA Processing and Function

34

1 reference

https://openalex.org/I4210148120

Chimeric Antigen Receptor T Cell Therapy

23

1 reference

https://openalex.org/I4210148120

Aetiology, Diagnosis, and Management of Myocarditis

20

1 reference

https://openalex.org/I4210148120

Viral Hemorrhagic Fevers and Zoonotic Infections

19

1 reference

https://openalex.org/I4210148120

Health Economics and Quality of Life Assessment

18

1 reference

https://openalex.org/I4210148120

Ebola Virus Research and Outbreaks

16

1 reference

https://openalex.org/I4210148120

Proximity-Dependent Protein Labeling in Living Cells

16

1 reference

https://openalex.org/I4210148120

Efficacy and Safety of Antiretroviral Therapy for HIV

16

1 reference

https://openalex.org/I4210148120

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome

16

1 reference

https://openalex.org/I4210148120

G-Quadruplex DNA Structures and Functions

16

1 reference

https://openalex.org/I4210148120

Molecular Mechanisms of Neurodegenerative Diseases

15

1 reference

https://openalex.org/I4210148120

Ribosome Structure and Translation Mechanisms

15

1 reference

https://openalex.org/I4210148120

Classification and Interventions for Cerebral Palsy

14

1 reference

https://openalex.org/I4210148120

Gastrointestinal Viral Infections and Vaccines Development

14

1 reference

https://openalex.org/I4210148120

Hepatitis B Infection and Treatment

13

1 reference

https://openalex.org/I4210148120

Tissue Engineering and Regenerative Medicine

12

1 reference

https://openalex.org/I4210148120

Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteins

12

1 reference

https://openalex.org/I4210148120

Hepatitis C Infection and Treatment

11

1 reference

https://openalex.org/I4210148120

Global Impact of Arboviral Diseases

11

1 reference

https://openalex.org/I4210148120

coordinate location

42°22'30"N, 71°6'20"W

1 reference

https://openalex.org/I4210148120

United States of America

1 reference

https://openalex.org/I4210148120

official website

https://www.sarepta.com/

1 reference

https://openalex.org/I4210148120

0 references

Research Organization Registry ID

0 references

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333576&oldid=1269985"